“Cancer patients treated on clinical trials lived substantially longer than those not treated on trial.” -Journal of ClinicalOncology, 2018 using 12 million patient registry data from National Cancer Database
Clinical trials help advance research and treatment options for cancer patients. If you have an advanced cancer, a rare cancer, or a cancer that has not responded to standard treatment options, exploring a clinical trial may be your best option.
New clinical trials added on Sep 29, 2023
Assessing Social Determinants of Health to Increase Cancer Screening
NCT Number : NCT06052449
Strength After Breast Cancer
NCT Number : NCT06052488
A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men
NCT Number : NCT06052202
NV-001 in the Treatment of Advanced Solid Tumors
NCT Number : NCT06051760
SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology
NCT Number : NCT06053086
ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer
NCT Number : NCT06052423
Efficacy and Safety of SCRT Versus TNT in Older Patients With Locally Advanced Rectal Cancer
NCT Number : NCT06052332
Music Breathing for Caregivers of Children Newly Diagnosed With Cancer
NCT Number : NCT06052904
Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes
NCT Number : NCT06052345
A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Men With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT Number : NCT06052306
Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer
NCT Number : NCT06052098
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
NCT Number : NCT06051695
Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC
NCT Number : NCT06052839
A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.
NCT Number : NCT06052683
Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer
NCT Number : NCT06051851
Investigation of the Efficiency of Pain Neuroscience Education in Patients With Chronic Pain After Breast Cancer Surgery
NCT Number : NCT06052085
Study of BDC-3042 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Malignancies
NCT Number : NCT06052852
Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
NCT Number : NCT06052618
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
NCT Number : NCT06051942
Social Determinants of Health in Hepatobiliary Cancer Patients
NCT Number : NCT06053333
A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)
NCT Number : NCT06053099
Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL
NCT Number : NCT06052696
Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors
NCT Number : NCT06053268
A Multicenter RWS Study Comparing the Benefits of Continued Use of OFS After 5 Years
NCT Number : NCT06050109
Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance
NCT Number : NCT06043973
A Study of BN104 in the Treatment of Acute Leukemia
NCT Number : NCT06052813
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
NCT Number : NCT06052826
Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea)
NCT Number : NCT06051747
A Study to Evaluate Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
NCT Number : NCT06052059
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
NCT Number : NCT06053567
A Study of Adipose Tissue in Adaptive Responses to Exercise
NCT Number : NCT06053125
Turkish Version of the Worry About Pain Questionnaire
NCT Number : NCT06052228
The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye
NCT Number : NCT06043908
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 (THYTECH2)
NCT Number : NCT06052436
Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
NCT Number : NCT04551131
Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection
NCT Number : NCT06052033
Somatic Mosaicism in Twins Discordant for Childhood Cancer
NCT Number : NCT06054295
Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
NCT Number : NCT06054854
A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors
NCT Number : NCT06055166
Multisite Implementation of COMPRENDO
NCT Number : NCT06055296
Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study
NCT Number : NCT06054308
SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer
NCT Number : NCT06055348
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System
NCT Number : NCT06054867
Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer
NCT Number : NCT06055465
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
NCT Number : NCT06055439
Study of ALE.C04 in Patients With Head and Neck Cancer
NCT Number : NCT06054477
Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)
NCT Number : NCT06053775
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
NCT Number : NCT06053658
Hepatopulmonary Radio-sterilization With Immunotherapy
NCT Number : NCT06053996
TCR-T Cells in the Treatment of Advanced Pancreatic Cancer
NCT Number : NCT06054984
Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer
NCT Number : NCT06054789
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer
NCT Number : NCT06054906
Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
NCT Number : NCT06054529
Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
NCT Number : NCT06054776
Improving Pancreatic Cancer Care by the Use of Computational Science and Technology
NCT Number : NCT06055010
Frailty Assessment and Intervention in Elderly Patients With Gastric Cancer Receiving Gastrectomy and Adjuvant Chemotherapy
NCT Number : NCT06055387
Hand-Foot Exercises on Peripheral Neuropathy
NCT Number : NCT06055088
Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors
NCT Number : NCT06054932
Association Between Body Composition and Digestive System Cancer Survival
NCT Number : NCT06054685
PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis
NCT Number : NCT06055231
Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations
NCT Number : NCT06054191
A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma
NCT Number : NCT06055075
Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible
NCT Number : NCT06055257
Identification of Nerves Using Fluorescein Sodium
NCT Number : NCT06054178
CX3CR1+T Cell Predict Immunotherapy Efficacy
NCT Number : NCT06054152
Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)
NCT Number : NCT06055517
DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC
NCT Number : NCT06055153
A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China
NCT Number : NCT06053801
Reshaping Postpartum Follow-up
NCT Number : NCT06054841
XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)
NCT Number : NCT06055179
Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients
NCT Number : NCT06055543
The Effect of Bed Bath Applied to Palliative Care Patients on Saturation, Pain Level and Sleep Quality
NCT Number : NCT06055426
Study on Vaginal Microecology and Cervical Local Immune Function in Patients With Uterine Fibroids of Childbearing Age
NCT Number : NCT06055114
Effects of Intradialytic Aerobic Exercise in Chronic Kidney Patients
NCT Number : NCT06055283
Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
NCT Number : NCT06054113
A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma
NCT Number : NCT06054555
Effect of Short-chain Fatty Acids on Aerobic Endurance
NCT Number : NCT06054607
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
NCT Number : NCT06058377
Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR
NCT Number : NCT06057350
PET/MRI in Rectal Cancer
NCT Number : NCT06057831
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
NCT Number : NCT06059118
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
NCT Number : NCT06056804
IMaC - Immune Pathways in Oesophagogastric Cancer
NCT Number : NCT06057220
A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors
NCT Number : NCT06057038
Heart Health After Cancer Treatment (HEART-ACT)
NCT Number : NCT06055803
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy.
NCT Number : NCT06056830
Exercises Using Virtual Reality on Cancer Patients
NCT Number : NCT06058936
A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer
NCT Number : NCT06057610
A Study of HB0045 Injection in Patients With Advanced Solid Tumors
NCT Number : NCT06056323
Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer
NCT Number : NCT06059014
Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung Cancer
NCT Number : NCT06057766
A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus
NCT Number : NCT06056024
Study of INKmune in Patients With mCRPC (CaRe Prostate)
NCT Number : NCT06056791
Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors
NCT Number : NCT06059508
Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study
NCT Number : NCT06059495
Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
NCT Number : NCT06059261
The Effects of Metabolic & Bariatric Surgery on Lipid Metabolism, Myeloid-Derived Suppressor Cells, and Cancer Cell Biology
NCT Number : NCT06059651
INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) for the Treatment of Advanced or Metastatic PD-(L)1 Refractory Merkle Cell Carcinoma
NCT Number : NCT06056895
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
NCT Number : NCT06055868
Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)
NCT Number : NCT06056310
Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
NCT Number : NCT06058793
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
NCT Number : NCT06058988
Radioembolization With Tremelimumab and Durvalumab for Locally Advanced, Unresectable Intrahepatic Cholangiocarcinoma
NCT Number : NCT06058663
Evaluation of Intra- and Peri-operative Complications and Disease-free Survival in Rectal Cancer Patients Undergoing Oncological Resective Surgery and Concomitant Bariatric Surgery
NCT Number : NCT06056726
Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy
NCT Number : NCT06056505
Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE
NCT Number : NCT06055621
Nutritional Intervention for Patients With Multiple Cancer Types
NCT Number : NCT06059560
A Study YL201 in Patients With Selected Advanced Solid Tumors
NCT Number : NCT06057922
Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy
NCT Number : NCT06055946
Handheld Ultrasound Device to Triage Women With a Positive Clinical Breast Examination by Trained Non-radiologists
NCT Number : NCT06056843
Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC
NCT Number : NCT06059001
Individual Food Preferences for the Mediterranean Diet in Cancer Patients
NCT Number : NCT06058312
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
NCT Number : NCT06057636
Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
NCT Number : NCT06055738
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)
NCT Number : NCT03896646
Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation
NCT Number : NCT06056414
PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.
NCT Number : NCT06059469
Neoadjuvant Immunotherapy in Combination With the Anti-GDF-15 Antibody Visugromab (CTL-002) for Treatment of Muscle Invasive Bladder Cancer
NCT Number : NCT06059547
Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors
NCT Number : NCT06056362
Project Looking-Glass Evaluation
NCT Number : NCT06056063
Impact of Patient-Centered Approach for Communicating Coronary Calcium on Cardiovascular Health
NCT Number : NCT06055972
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
NCT Number : NCT01709435
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy (BOSS)
NCT Number : NCT06055881
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
NCT Number : NCT06059586
Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC)
NCT Number : NCT06057298
Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma
NCT Number : NCT06060080
A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy
NCT Number : NCT06058741
Impact of Augmented Reality During Robot-assisted Radical Prostatectomy
NCT Number : NCT06059859
Multiple Myeloma Yoga Pilot Study
NCT Number : NCT06061302
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
NCT Number : NCT06055816
Tranexamic Acid in Nasal Mohs Reconstruction
NCT Number : NCT06057675
Confirmation of Accuracy of the Tool-in-lesion Technology (TiLT) of the Galaxy System With Integrated TOMO Technology
NCT Number : NCT06056128
Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
NCT Number : NCT06055790
Safety and Efficacy of OBX-115 in Advanced/Metastatic Melanoma Resistant to Immune Checkpoint Inhibitors
NCT Number : NCT06060613
CPX-351 Plus Enasidenib for Relapsed AML
NCT Number : NCT03825796
Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging
NCT Number : NCT06060769
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
NCT Number : NCT06058650
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
NCT Number : NCT06059391
Endoscopic Ultrasound- Guided Hartmann Reversal Procedure
NCT Number : NCT06061432
Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
NCT Number : NCT06056115
The Pancreatic Enzymes After Gastrectomy Trial
NCT Number : NCT06058442
New Method to Differentiate Benign and Malignant Pulmonary Nodules.
NCT Number : NCT06056999
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
NCT Number : NCT06057948
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
NCT Number : NCT06057935
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM)
NCT Number : NCT06055894
Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia
NCT Number : NCT06058572
Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas
NCT Number : NCT06057168
Adapting, Expanding and Evaluating ARCHES in Kenya
NCT Number : NCT06059196
Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
NCT Number : NCT06060561
Omega Gastric Bypass (150cm) Compared to the Roux-en-Y Gastric Bypass
NCT Number : NCT06057597
Serum Magnesium Level in Type 2 Diabetes Mellitus
NCT Number : NCT06059833
Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasis
NCT Number : NCT06055699
Project OASIS: Optimizing Approaches to Select Implementation Strategies
NCT Number : NCT06061328
The Effects of Aronia Melanocarpa Extract on Obese Individuals With Impaired Fasting Blood Glucose
NCT Number : NCT06057389
A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
NCT Number : NCT06058728
Role of FDG PET/CT in Patients With Metastasis of Unknown Origin
NCT Number : NCT06055764
Intraoperative Blood Loss Under Standard Versus Low Pneumoperitoneum Pressure During Laparoscopic Liver Resection.
NCT Number : NCT06060899
Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis
NCT Number : NCT06058858
Non-contrast Magnetic Resonance Angiography in Deep Inferior Epigastric Perforator Flap Breast Reconstruction Planning
NCT Number : NCT06061835
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
NCT Number : NCT06056336
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
NCT Number : NCT06060028
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
NCT Number : NCT06057402
Digital Tool Enhancing GPs' Information Management for Patients With Multimorbidity - a Pilot Study
NCT Number : NCT06061172
Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
NCT Number : NCT06061094
Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor
NCT Number : NCT06057571
Shwachman Diamond Syndrome Registry and Study
NCT Number : NCT06056908
SIRT1(rs7069102 ) Gene Polymorphism in Chronic Obstructive Pulmonary Disease at Egyptian Patients
NCT Number : NCT06055634
Effect of Indoor Plants on Cardiopulmonary System
NCT Number : NCT06060145
Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy
NCT Number : NCT06056687
Gut Microbiota in Metabolic Surgery
NCT Number : NCT05000996
Bruni® Training in OPHL Patients
NCT Number : NCT06058273
Lamivudine and Plasma Markers of Inflammation in Retinal Detachment
NCT Number : NCT06056596
Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine
NCT Number : NCT06060782
Individual Determinants of Postprandial Glucose Response in Type 2 Diabetes
NCT Number : NCT06057246
QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
NCT Number : NCT06056752
LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs
NCT Number : NCT06060912
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
NCT Number : NCT06061809
Frequency ,Etiology and Prognostic Factors of Acute Transverse Myelitis
NCT Number : NCT06055998
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
NCT Number : NCT06055959
A PROSPECTIVE STUDY ON THE ROLE OF KARL STORZ CURVED AND STRAIGHT FETOSCOPES (11508AAK and 11506AAK) FOR FETOSCOPIC INTRAUTERINE PROCEDURES
NCT Number : NCT06056635
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
NCT Number : NCT06056921
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM)
NCT Number : NCT05489705
inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease
NCT Number : NCT06059989
Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules
NCT Number : NCT06056882
Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)
NCT Number : NCT06060847
Enter a few details below to get started and we'll help you match up with active clinical trials
9097 Trials found
Cancer Details
Eligibility Criteria
Location
OncoPower Clinical Trial Features
Fill out your profile and we’ll match you with clinical trial opportunities that are tailored to you
We work directly with the researchers on your behalf to cut through the pile of paperwork and streamline inclusion and exclusion criteria
Our team will connect you with financial resources available to clinical trial participants
OncoPower works with the sponsoring organization to make sure you don’t have to do things twice when being onboarded with a clinical trial
Clinical trials for cancer often compare a new drug or treatment modality with the current standard of care. Depending on the trial, you may be able to stay on your current medication. In addition to that, some Clinical trials in cancer are observational and follow a large population over several years and try to understand how other factors impact disease progression and survivorship. These often allow you to continue your course of treatment with your current team and answer survey questions from the research team.
There are some clinical trials that provide compensation and/or reimbursement for expenses. One advantage of using OncoPower to identify and connect with the right clinical trial is that we do some of this legwork for you. Our team will help identify and connect you with financial benefits open to you (some through the study sponsor, some through outside non-profits).
Time spent will vary greatly depending on the clinical trial and treatment being studied. OncoPower will help you understand this as you will find this information out during the informed consent process.
You are able to leave a clinical trial at any time, for any reason.
Every clinical trial has unique and specific inclusion and exclusion criteria that help the researchers. If you don’t qualify for a trial you’re interested in but would like to learn about more trials, simply fill out your patient profile on OncoPower and indicate that you’re interested in Clinical Trials and we’ll help match you to suitable trials.
Joan-Smith
Virginia, United States
ChuckHastings
Florida, United States
DebraPearl
Pennsylvania, United States
Jennweeks
Iowa , United States
PatrickDW
Western Cape, South Africa
Jamie-Alexander
Floroda United States
CJ
Liz
Florida, United States
NYCynthia
New York, United States
Ferdi
California, United States
Begin offering a comprehensive digital experience for your patients.
Enter your E-mail address to receive your results